vs
Avantor, Inc.（AVTR）とPost Holdings, Inc.（POST）の財務データ比較。上の社名をクリックして会社を切り替えられます
Post Holdings, Inc.の直近四半期売上が大きい（$2.2B vs $1.7B、Avantor, Inc.の約1.3倍）。Post Holdings, Inc.の純利益率が高く（4.5% vs 3.1%、差は1.3%）。Post Holdings, Inc.の前年同期比売上増加率が高い（10.1% vs -1.4%）。Post Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$119.3M vs $117.2M）。過去8四半期でPost Holdings, Inc.の売上複合成長率が高い（4.3% vs -0.5%）
アバンター社は米国ペンシルベニア州ラドノーに本社を置くバイオテクノロジー・化学・医薬品企業です。1904年にJ.T.ベイカーとして創業し2010年に現社名に変更、2019年にNY証券取引所に上場し、証券コードは「AVTR」で、世界中のライフサイエンス分野の顧客に製品を提供しています。
Post Holdings, Inc.はアメリカの代表的な包装消費財食品メーカーで、主力事業にPost Consumer Brandsを有し、本社はミネソタ州レイクビルに所在します。同社が製造する各種食品は北米を中心に世界各国で販売され、多くの消費者に支持されています。
AVTR vs POST — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.7B | $2.2B |
| 純利益 | $52.4M | $96.8M |
| 粗利率 | 31.5% | 29.4% |
| 営業利益率 | 7.6% | 11.0% |
| 純利益率 | 3.1% | 4.5% |
| 売上前年比 | -1.4% | 10.1% |
| 純利益前年比 | -89.5% | -14.6% |
| EPS（希薄化後） | $0.08 | $1.71 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.6B | $2.2B | ||
| Q2 25 | $1.7B | $2.0B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.7B | $2.0B | ||
| Q3 24 | $1.7B | $2.0B | ||
| Q2 24 | $1.7B | $1.9B | ||
| Q1 24 | $1.7B | $2.0B |
| Q4 25 | $52.4M | $96.8M | ||
| Q3 25 | $-711.8M | $51.0M | ||
| Q2 25 | $64.7M | $108.8M | ||
| Q1 25 | $64.5M | $62.6M | ||
| Q4 24 | $500.4M | $113.3M | ||
| Q3 24 | $57.8M | $81.6M | ||
| Q2 24 | $92.9M | $99.8M | ||
| Q1 24 | $60.4M | $97.2M |
| Q4 25 | 31.5% | 29.4% | ||
| Q3 25 | 32.4% | 26.8% | ||
| Q2 25 | 32.9% | 30.0% | ||
| Q1 25 | 33.8% | 28.0% | ||
| Q4 24 | 33.4% | 30.1% | ||
| Q3 24 | 32.9% | 28.6% | ||
| Q2 24 | 34.1% | 29.6% | ||
| Q1 24 | 34.0% | 29.0% |
| Q4 25 | 7.6% | 11.0% | ||
| Q3 25 | -40.0% | 7.5% | ||
| Q2 25 | 7.7% | 11.8% | ||
| Q1 25 | 9.3% | 9.3% | ||
| Q4 24 | 37.8% | 10.8% | ||
| Q3 24 | 7.3% | 9.5% | ||
| Q2 24 | 10.3% | 10.4% | ||
| Q1 24 | 8.7% | 9.5% |
| Q4 25 | 3.1% | 4.5% | ||
| Q3 25 | -43.8% | 2.3% | ||
| Q2 25 | 3.8% | 5.5% | ||
| Q1 25 | 4.1% | 3.2% | ||
| Q4 24 | 29.7% | 5.7% | ||
| Q3 24 | 3.4% | 4.1% | ||
| Q2 24 | 5.5% | 5.1% | ||
| Q1 24 | 3.6% | 4.9% |
| Q4 25 | $0.08 | $1.71 | ||
| Q3 25 | $-1.04 | $0.91 | ||
| Q2 25 | $0.09 | $1.79 | ||
| Q1 25 | $0.09 | $1.03 | ||
| Q4 24 | $0.73 | $1.78 | ||
| Q3 24 | $0.08 | $1.28 | ||
| Q2 24 | $0.14 | $1.53 | ||
| Q1 24 | $0.09 | $1.48 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $365.4M | $279.3M |
| 総負債低いほど良い | $3.9B | $7.5B |
| 株主資本純資産 | $5.6B | $3.5B |
| 総資産 | $11.8B | $13.0B |
| 負債/資本比率低いほどレバレッジが低い | 0.71× | 2.16× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $365.4M | $279.3M | ||
| Q3 25 | $251.9M | $176.7M | ||
| Q2 25 | $449.4M | $1.1B | ||
| Q1 25 | $315.7M | $617.6M | ||
| Q4 24 | $261.9M | $872.9M | ||
| Q3 24 | $285.3M | $787.4M | ||
| Q2 24 | $272.6M | $333.8M | ||
| Q1 24 | $234.9M | $333.4M |
| Q4 25 | $3.9B | $7.5B | ||
| Q3 25 | $3.9B | $7.4B | ||
| Q2 25 | $4.2B | $7.3B | ||
| Q1 25 | $4.1B | $6.9B | ||
| Q4 24 | $4.1B | $6.9B | ||
| Q3 24 | $4.9B | $6.8B | ||
| Q2 24 | $5.1B | $6.4B | ||
| Q1 24 | $5.3B | $6.4B |
| Q4 25 | $5.6B | $3.5B | ||
| Q3 25 | $5.6B | $3.8B | ||
| Q2 25 | $6.3B | $4.0B | ||
| Q1 25 | $6.1B | $3.8B | ||
| Q4 24 | $6.0B | $3.9B | ||
| Q3 24 | $5.6B | $4.1B | ||
| Q2 24 | $5.4B | $3.9B | ||
| Q1 24 | $5.3B | $4.0B |
| Q4 25 | $11.8B | $13.0B | ||
| Q3 25 | $11.7B | $13.5B | ||
| Q2 25 | $12.8B | $13.4B | ||
| Q1 25 | $12.3B | $12.8B | ||
| Q4 24 | $12.1B | $12.8B | ||
| Q3 24 | $12.8B | $12.9B | ||
| Q2 24 | $12.7B | $12.1B | ||
| Q1 24 | $12.8B | $12.2B |
| Q4 25 | 0.71× | 2.16× | ||
| Q3 25 | 0.69× | 1.98× | ||
| Q2 25 | 0.67× | 1.84× | ||
| Q1 25 | 0.67× | 1.81× | ||
| Q4 24 | 0.68× | 1.79× | ||
| Q3 24 | 0.89× | 1.67× | ||
| Q2 24 | 0.94× | 1.62× | ||
| Q1 24 | 1.00× | 1.61× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $152.7M | $235.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $117.2M | $119.3M |
| FCFマージンFCF / 売上 | 7.0% | 5.5% |
| 設備投資強度設備投資 / 売上 | 2.1% | 5.4% |
| キャッシュ転換率営業CF / 純利益 | 2.91× | 2.43× |
| 直近12ヶ月FCF直近4四半期 | $495.0M | $436.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $152.7M | $235.7M | ||
| Q3 25 | $207.4M | $301.3M | ||
| Q2 25 | $154.4M | $225.9M | ||
| Q1 25 | $109.3M | $160.7M | ||
| Q4 24 | $173.3M | $310.4M | ||
| Q3 24 | $244.8M | $235.4M | ||
| Q2 24 | $281.1M | $272.3M | ||
| Q1 24 | $141.6M | $249.6M |
| Q4 25 | $117.2M | $119.3M | ||
| Q3 25 | $171.7M | $151.6M | ||
| Q2 25 | $124.8M | $94.9M | ||
| Q1 25 | $81.3M | $70.2M | ||
| Q4 24 | $145.8M | $171.4M | ||
| Q3 24 | $204.0M | $96.2M | ||
| Q2 24 | $235.3M | $161.5M | ||
| Q1 24 | $106.9M | $150.9M |
| Q4 25 | 7.0% | 5.5% | ||
| Q3 25 | 10.6% | 6.7% | ||
| Q2 25 | 7.4% | 4.8% | ||
| Q1 25 | 5.1% | 3.6% | ||
| Q4 24 | 8.6% | 8.7% | ||
| Q3 24 | 11.9% | 4.8% | ||
| Q2 24 | 13.8% | 8.3% | ||
| Q1 24 | 6.4% | 7.5% |
| Q4 25 | 2.1% | 5.4% | ||
| Q3 25 | 2.2% | 6.7% | ||
| Q2 25 | 1.8% | 6.6% | ||
| Q1 25 | 1.8% | 4.6% | ||
| Q4 24 | 1.6% | 7.0% | ||
| Q3 24 | 2.4% | 6.9% | ||
| Q2 24 | 2.7% | 5.7% | ||
| Q1 24 | 2.1% | 4.9% |
| Q4 25 | 2.91× | 2.43× | ||
| Q3 25 | — | 5.91× | ||
| Q2 25 | 2.39× | 2.08× | ||
| Q1 25 | 1.69× | 2.57× | ||
| Q4 24 | 0.35× | 2.74× | ||
| Q3 24 | 4.24× | 2.88× | ||
| Q2 24 | 3.03× | 2.73× | ||
| Q1 24 | 2.34× | 2.57× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
POST
| Post Consumer Brands Segment | $1.1B | 51% |
| Pet Food | $360.4M | 17% |
| Side Dishes | $221.5M | 10% |
| Weetabix | $137.9M | 6% |
| Other | $122.1M | 6% |
| Nut Butters | $105.8M | 5% |
| Sausage | $53.1M | 2% |
| Cheeseand Dairy | $41.3M | 2% |
| Protein Based Shakes | $29.3M | 1% |
| Bell Ring | $18.1M | 1% |
